Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -8.80% is 97% below its 5-year average of -4.48%, around the middle of its 5-year range (-17.04%–9.21%).
As of the fiscal period ended Wednesday, December 31, 2025. 36.87% above its 12-month average of -13.93%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -8.80%.
RETURN ON EQUITY (ROE)
-8.80%
RETURN ON EQUITY (ROE) AVG TTM
-13.93%
RETURN ON EQUITY (ROE) AVG 3Y
-8.61%
RETURN ON EQUITY (ROE) AVG 5Y
-4.48%
RETURN ON EQUITY (ROE) AVG 10Y
-8.60%
RETURN ON EQUITY (ROE) AVG 15Y
-12.59%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+36.87%
CURRENT VS 3Y AVG
-2.15%
CURRENT VS 5Y AVG
-96.57%
CURRENT VS 10Y AVG
-2.30%
CURRENT VS 15Y AVG
+30.14%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.09%
median of 543 covered companies
CURRENT VS SECTOR MEDIAN
+78.06%
vs the sector median at left
InterCure Ltd.
Market Cap
$64.68M
Return on Equity (ROE)
-8.80%
TTM Avg
-13.93%
3Y Avg
-8.61%
5Y Avg
-4.48%
Market Cap
$64.94M
Return on Equity (ROE)
N/A
TTM Avg
-26.44%
3Y Avg
-559.66%
5Y Avg
-417.87%
Market Cap
$64.71M
Return on Equity (ROE)
-492.89%
TTM Avg
-50.27%
3Y Avg
-279.07%
5Y Avg
-249.48%
Market Cap
$63.30M
Return on Equity (ROE)
-76.75%
TTM Avg
-53.49%
3Y Avg
-5.79%
5Y Avg
-19.88%
Market Cap
$63.23M
Return on Equity (ROE)
N/A
TTM Avg
140.07%
3Y Avg
68.30%
5Y Avg
45.41%
Market Cap
$66.27M
Return on Equity (ROE)
-122.71%
TTM Avg
-558.46%
3Y Avg
-307.41%
5Y Avg
-314.14%
Market Cap
$61.79M
Return on Equity (ROE)
N/A
TTM Avg
-285.38%
3Y Avg
-206.98%
5Y Avg
-151.57%
Market Cap
$67.60M
Return on Equity (ROE)
68.12%
TTM Avg
-94.32%
3Y Avg
-166.28%
5Y Avg
-128.51%
Market Cap
$68.49M
Return on Equity (ROE)
-38.55%
TTM Avg
-81.03%
3Y Avg
-175.38%
5Y Avg
-133.71%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InterCure Ltd. (INCR) | $64.68M | -8.80% | -13.93% | -8.61% | -4.48% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.94M | N/A | -26.44% | -559.66% | -417.87% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.71M | -492.89% | -50.27% | -279.07% | -249.48% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | -76.75% | -53.49% | -5.79% | -19.88% |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | 140.07% | 68.30% | 45.41% |
| Cingulate Inc. (CING)vs › | $66.27M | -122.71% | -558.46% | -307.41% | -314.14% |
| PDS Biotechnology Corporation (PDSB)vs › | $61.79M | N/A | -285.38% | -206.98% | -151.57% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.60M | 68.12% | -94.32% | -166.28% | -128.51% |
| iBio, Inc. (IBIO)vs › | $68.49M | -38.55% | -81.03% | -175.38% | -133.71% |
| Adicet Bio, Inc. (ACET)vs › | $60.30M | -82.38% | -68.06% | -60.95% | -49.61% |
ROE
-8.8%
ROA
-5.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -8.80% |
| 2025-09-30 | -12.63% |
| 2025-06-30 | -15.10% |
| 2025-03-31 | -16.26% |
| 2024-12-31 | -16.88% |
| 2024-09-30 | -17.04% |
| 2024-06-30 | -14.47% |
| 2024-03-31 | -13.25% |
| 2023-12-31 | -13.27% |
| 2023-09-30 | -4.17% |
| 2023-06-30 | 4.26% |
| 2023-03-31 | 6.45% |
| 2022-12-31 | 9.21% |
| 2022-09-30 | 7.06% |
| 2022-06-30 | 5.22% |
| 2022-03-31 | 3.17% |
| 2021-12-31 | 0.94% |
| 2021-09-30 | 3.92% |
| 2021-06-30 | 4.77% |
| 2021-03-31 | 4.83% |
| 2020-12-31 | -11.94% |
| 2020-09-30 | -22.23% |
| 2020-06-30 | -35.55% |
| 2020-03-31 | -41.79% |
| 2019-12-31 | -1.71% |
| 2019-09-30 | 8.93% |
| 2019-06-30 | 6.49% |
| 2019-03-31 | 140.09% |
| 2018-12-31 | -66.77% |
| 2018-09-30 | -53.45% |
| 2018-06-30 | -48.14% |
| 2018-03-31 | -39.57% |
| 2017-12-31 | -26.40% |
| 2017-09-30 | -19.18% |
| 2017-06-30 | -12.30% |
| 2017-03-31 | -10.34% |
| 2016-12-31 | 1.19% |
| 2016-09-30 | -2.42% |
| 2016-06-30 | -10.89% |
| 2016-03-31 | -2.81% |
| 2015-12-31 | -15.61% |
| 2015-09-30 | -12.47% |
| 2015-06-30 | -16.04% |
| 2015-03-31 | -26.43% |
| 2014-12-31 | -570.95% |
| 2014-09-30 | -483.28% |
| 2014-06-30 | -260.33% |
| 2014-03-31 | -159.48% |
| 2013-12-31 | -165.99% |
| 2013-09-30 | -118.61% |
| 2013-06-30 | 478.58% |
| 2013-03-31 | 528.88% |
| 2012-12-31 | 418.93% |
| 2012-09-30 | 471.93% |
| 2012-06-30 | -302.65% |
| 2012-03-31 | -347.09% |
